Christopher Posner, President & CEO, LEO Pharma Inc. - Region U.S.
Judit H. Nyirady, Vice President, Medical Strategy & Scientific Affairs
Dr. Judit Nyirady joined LEO Pharma Inc. in May 2017 as the Vice President of Medical Strategy & Scientific Affairs. Dr. Nyirady is responsible for the medical and scientific affairs strategies for LEO Pharma U.S., as well as the U.S. Quality, Pharmacovigilance, Drug Safety and Medical Information functions.
Prior to joining LEO, Dr. Nyirady worked at Novartis as interim Medical Unit Head of Dermatology & Immunology - U.S. Clinical Development & Medical Affairs, and Executive Director of Dermotology in U.S. Clinical Development & Medical Affairs. Before joining Novartis, Dr. Nyirady worked at Johnson & Johnson Consumer Products Worldwide in Medical Affairs - Dermatology.
Dr. Nyirady holds a M.B.A. from Cornell University, Johnson Graduate School of Management and obtained her medical degree in Hungary from Albert Szent-Gyorgyi Medical University.
Keith Bernius, Vice President, Finance
Keith Bernius joined LEO Pharma Inc. in April 2014 as the Vice President, Finance. Mr. Bernius is responsible for the overall management of the U.S. Finance function with responsibility of business finance, accounting & tax, contract & pricing, trade and supervision of IT and procurement activities.
Prior to joining LEO, Mr. Bernius was the Vice President of Finance and Treasurer of Altegrity Inc. in NYC where he has been responsible for global treasury, investor relations, risk management, enterprise FP&A and real estate. Prior to Altegrity, he worked at Alpharma Pharmaceuticals for seven years serving in both corporate finance and divisional roles. In his last position at Alpharma as Vice President, Finance and Pharmaceuticals CFO, Mr. Bernius was responsible for finance, trade and commercial operations functions.
Mr. Bernius holds a Bachelor of Science Degree in Accounting from Manhattan College and is a Certified Public Accountant.
Mitch Johnson, VP, Sales
Mitchell (Mitch) Johnson joined LEO Pharma Inc. as Vice President of Sales in July 2015. Mr. Johnson is responsible for the enhancement and expansion of the efforts of the LEO U.S. sales team, in addition to managing the sales training and sales operations functions in the region.
Mr. Johnson has over 25 years of experience in the pharmaceutical industry with an emphasis in sales management. Prior to joining LEO, he held the position as Vice President, Sales - Respiratory at GlaxoSmithKline. While at GlaxoSmithKline, Mr. Johnson also held positions as Executive Director of the Influenza Franchise, Regional Sales Vice President of General Pharma, and Product Manager in the Diabetes Franchise. Prior to joining the pharmaceutical industry, he played professional baseball for a total of 10 years with the Boston Red Sox and Houston Astros.
Johnson holds a Bachelor of Science in Business Administration from Bryant University in Rhode Island and a Masters of Business Administration from Duke University in Durham, North Carolina.
Domenic Verroca, VP, Patient Market Access & Public Affairs
Domenic Verroca, Ph.D. joined LEO Pharma U.S. as Vice President of Market Access & Public Affairs in July 2015.
Mr. Verroca joins LEO Pharma after serving as Vice President of Market Access at Galderma. Prior to Galderma, Verroca worked at Sanofi for over 11 years in positions of increasing responsibility. His last position at Sanofi was as Vice President of U.S. Market Access – a position he held for over 6 years. He also worked for Pharmacia and Johnson & Johnson Health Care Systems.
Verroca holds a B.A. in Economics and Geography from Coventry University in England, a M.A. in International Affairs from Drew University and a Ph.D. in Management from the University of Pittsburgh.
Doreen V. Morgan, VP, U.S. Regulatory Affairs
Kylie O'Keefe, Director, Strategic Marketing
Tiffany L. Christian, Director, Legal
Tiffany L. Christian joined LEO Pharma in August 2013 as Associate Director, Legal and was promoted to the position of Director, Legal in January 2015.
As the Director of Legal, Ms. Christian is responsible for managing and overseeing all legal activities for the U.S. Region and she functions as the chief legal officer for LEO Pharma U.S. Ms. Christian provides commercial and regulatory support on the company’s marketed products, as well as support on issues relating to the company’s drug development programs and pipelines in the U.S. In addition, Ms. Christian provides guidance and training to various internal functional areas on FDA laws and regulations, consumer protections laws, and other relevant laws and regulations governing the commercialization of pharmaceutical products in the U.S.
Prior to joining LEO Pharma, Ms. Christian held the position of Counsel, Pharmaceuticals at Warner Chilcott (U.S.) LLC. While at Warner Chilcott, she provided general counsel and advice to the specialty pharmaceutical company concerning matters affecting the company’s U.S. operations, with a focus on the advertising and promotion of its products. Prior to Warner Chilcott, Ms. Christian was a Commercial Litigation/Product Liability Associate at DLA Piper LLP (U.S.) and before that at Sills Cummis & Gross P.C.
Ms. Christian holds a Juris Doctor from Georgetown University Law Center in Washington DC and a Bachelor of Arts from Cornell University in Ithaca, New York.
Lars Bukhave Rasmussen, Vice President, Patient Solutions
Lars Bukhave Rasmussen joined LEO U.S. as Vice President of Patient Solutions in August 2016. In his role Mr. Rasmussen is responsible for the development and execution of marketing strategies for both the Psoriasis and Actinic Keratosis (AK) franchises and the PRISM organization (Patient Relations, Insights and Stakeholder Engagement and Quality Care), in addition to championing the company’s patient-centric philosophy and business model.